Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.

McArthur S, Gillies GE.

Front Endocrinol (Lausanne). 2011 Nov 30;2:82. doi: 10.3389/fendo.2011.00082.

Direct interaction of α-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease.

Chung JY, Lee SJ, Lee SH, Jung YS, Ha NC, Seol W, Park BJ.

Neurosignals. 2011;19(2):86-96. doi: 10.1159/000325028.

Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: clinical, anatomical and functional imaging study.

Ulla M, Thobois S, Llorca PM, Derost P, Lemaire JJ, Chereau-Boudet I, de Chazeron I, Schmitt A, Ballanger B, Broussolle E, Durif F.

J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):607-14. doi: 10.1136/jnnp.2009.199323.

Factors associated with exercise behavior in people with Parkinson disease.

Ellis T, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Fredman L, Boudreau JK, Dibble LE.

Phys Ther. 2011 Dec;91(12):1838-48. doi: 10.2522/ptj.20100390.

Temporomandibular disorders in patients with craniocervical dystonia.

Costa AL, Campos LS, França Jr MC, D'Abreu A.

Arq Neuropsiquiatr. 2011 Dec;69(6):896-9.

A gene expression phenotype in lymphocytes from Friedreich ataxia patients.

Coppola G, Burnett R, Perlman S, Versano R, Gao F, Plasterer H, Rai M, Saccá F, Filla A, Lynch DR, Rusche JR, Gottesfeld JM, Pandolfo M, Geschwind DH.

Ann Neurol. 2011 Nov;70(5):790-804. doi: 10.1002/ana.22526.

Speech-induced cervical dystonia.

Bouchard M, Furtado S.

Can J Neurol Sci. 2011 Nov;38(6):929-30. No abstract available.

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.

Setó-Salvia N, Clarimón J, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Combarros O, Mateo JI, Regaña D, Martínez-Corral M, Marquié M, Alcolea D, Suárez-Calvet M, Molina-Porcel L, Dols O, Gómez-Is

Arch Neurol. 2011 Mar;68(3):359-64. doi: 10.1001/archneurol.2011.17.

Suicidal ideation in Huntington disease: the role of comorbidity.

Wetzel HH, Gehl CR, Dellefave-Castillo L, Schiffman JF, Shannon KM, Paulsen JS; Huntington Study Group..

Psychiatry Res. 2011 Aug 15;188(3):372-6. doi: 10.1016/j.psychres.2011.05.006.

Initial motor symptoms of Parkinson disease.

Garcia Ruiz PJ, Catalán MJ, Fernández Carril JM.

Neurologist. 2011 Nov;17(6 Suppl 1):S18-20. doi: 10.1097/NRL.0b013e31823966b4. Review.

Do nonmotor symptoms in Parkinson's disease differ from normal aging?

Krishnan S, Sarma G, Sarma S, Kishore A.

Mov Disord. 2011 Sep;26(11):2110-3. doi: 10.1002/mds.23826.

NSAID use and risk of Parkinson disease: a population-based case-control study.

Becker C, Jick SS, Meier CR.

Eur J Neurol. 2011 Nov;18(11):1336-42. doi: 10.1111/j.1468-1331.2011.03399.x.

Association between apolipoprotein E genotypes and Parkinson's disease.

Pulkes T, Papsing C, Mahasirimongkol S, Busabaratana M, Kulkantrakorn K, Tiamkao S.

J Clin Neurosci. 2011 Oct;18(10):1333-5. doi: 10.1016/j.jocn.2011.01.028.

Interleaving programming of subthalamic deep brain stimulation to reduce side effects with good motor outcome in a patient with Parkinson's disease.

Wojtecki L, Vesper J, Schnitzler A.

Parkinsonism Relat Disord. 2011 May;17(4):293-4. doi: 10.1016/j.parkreldis.2010.12.005. No abstract available.

Relation of risk factors and putative premotor markers for Parkinson's disease.

Liepelt-Scarfone I, Behnke S, Godau J, Schweitzer KJ, Wolf B, Gaenslen A, Berg D.

J Neural Transm (Vienna). 2011 Apr;118(4):579-85. doi: 10.1007/s00702-010-0553-x.